Overview
Use of NovoSeven® in Active Variceal Bleeding
Status:
Completed
Completed
Trial end date:
2006-08-01
2006-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is conducted in Asia and Europe. The trial is planned to investigate the effectiveness and safety of NovoSeven® in patients with advanced cirrhosis and active variceal bleeding.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:- Variceal bleeding